Picture of Intelgenx Technologies logo

IGX — Intelgenx Technologies News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Intelgenx Announces Resubmission Of Rizaport New Drug Application

Sept 26 (Reuters) - Intelgenx Technologies Corp  IGX.V :
    * INTELGENX ANNOUNCES RESUBMISSION OF RIZAPORT® NEW DRUG
APPLICATION
    * INTELGENX TECHNOLOGIES - RESUBMITTED ITS 505(B)(2) NEW
DRUG
APPLICATION FOR RIZAPORT VERSAFILM FOR TREATMENT OF ACUTE
MIGRAINES TO U.S. FDA

Source text for Eikon:  ID:nGNXbPvwZG 
Further company coverage:  IGX.V 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Intelgenx Technologies

See all news